Equities

Cleo Diagnostics Ltd

COV:ASX

Cleo Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.24
  • Today's Change0.07 / 41.18%
  • Shares traded2.19m
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of May 29 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • COV:ASX trading volume exceeds daily average by +1,000.38%
  • COV:ASX price reached a new 52-week high of 0.25 at 11:02 BST
  • COV:ASX price moved over +47.06% to 0.25
  • COV:ASX price rises above 50-day moving average to 0.25 at 11:02 BST
  • COV:ASX price rises above 15-day moving average to 0.25 at 11:02 BST

Key statistics

Cleo Diagnostics Ltd (COV:ASX) set a new 52-week high during today's trading session when it reached 0.2725. Over this period, the share price is up 14.29%.
52-week range
Today
0.14Jan 30 20240.2725May 29 2024
Open0.26
High0.2725
Low0.20
Bid0.235
Offer0.245
Previous close0.17
Average volume24.55k
Shares outstanding74.10m
Free float20.89m
P/E (TTM)--
Market cap12.60m AUD
EPS (TTM)-0.0305
AUD
Data delayed at least 20 minutes, as of May 29 2024 07:10 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.